An Artefact Related to the Ratio of Sample Volume to the Blood Collection Vial Size which Effects the APTTs of Specimens Taken to Monitor Heparin Therapy

Thromb Haemost 1991; 66(03): 387-388
DOI: 10.1055/s-0038-1646424

Letter to the Editor

Schattauer GmbH Stuttgart

Michael J Ray

Haematology Department, The Prince Charles Hospital, Rode Road, Chermside, Brisbane 4032, Australia

References
1 Heyns A du P, van den Berg DJ, Kleynhans PHT, du Toit PW. Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time. J Clin Pathol 1981; 34: 63-8
2 Cummings J. Evacuated tubes for monitoring heparin treatment: letter. J Clin Pathol 1981; 34: 939-40
3 Van den Besselar AMHP, Meeuwisse-Braun J, Jansen-Grüter R, Bertina RM. Monitoring heparin therapy by the activated partial thromboplastin time. Thromb Haemostas 1987; 57: 226-31
4 Coller BS. Disorders of platelets. In: Disorders of Haemostasis.. Ratnoff OD, Forbes CD. (eds) Grune and Stratton, Orlando, FL: 1984. pp 73-176
5 Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JRA. Platelet aggregation in whole blood determined using the Ultra-Flow 100 platelet counter. Thromb Haemostas 1982; 48: 327-9
6 Bell DN, Spain S, Goldsmith HL. The effect of red blood cells on the ADP induced aggregation on human platelets in flow through tubes. Thromb Haemostas 1990; 63: 112-21